Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India.
Department of Pharmacology and Toxicology, Faculty of Medicine, Umm Al-Qura University, Makkah, Saudi Arabia.
Drug Discov Today. 2021 Aug;26(8):1891-1903. doi: 10.1016/j.drudis.2021.02.013. Epub 2021 Feb 18.
Cancer vaccines consist of nucleic acid derivatives such as plasmid DNA, small interfering RNA and mRNA, and can be customized according to the patient's needs. Nanomedicines have proven to be exceptionally good as miniaturized drug carriers, and thus they offer great advantages for delivering cancer vaccines. This review provides an overview of the literature on cancer vaccines, from their inception to current developments in the field.
癌症疫苗由核酸衍生物组成,如质粒 DNA、小干扰 RNA 和 mRNA,并可根据患者的需求定制。纳米药物已被证明是非常好的微型药物载体,因此它们在递送癌症疫苗方面具有很大的优势。本文综述了癌症疫苗的文献,从其起源到该领域的当前发展。
Drug Discov Today. 2021-8
ACS Appl Bio Mater. 2024-8-19
J Control Release. 2024-6
Adv Genet. 2014
Expert Opin Drug Deliv. 2020-6
Angew Chem Int Ed Engl. 2011-7-25
J Gene Med. 2019-5-10
Curr Pharm Des. 2019
Cancer Commun (Lond). 2025-5
J Pharm Pharm Sci. 2024-7-24
Exploration (Beijing). 2023-11-17
Molecules. 2024-2-29
ACS Omega. 2024-1-30
Pharmaceuticals (Basel). 2023-1-1
Int J Mol Sci. 2022-10-18